Abstract
Psoriatic arthritis (PsA) is a multifaceted disease that challenges outcome methodologists. A number of measures have been used to define remission in PsA but they have been mostly articular. Composite measures of disease activity and low disease states are now emerging, but further work is required to assess the implications of achieving these goals and to develop cost-effective treatment strategies to achieve them.
Footnotes
-
Dr. Caperon is supported by Arthritis Research UK.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
